Immune profiling of critically ill patients with acute kidney injury during the first week after various types of injuries: the REALAKI study.
Acute kidney injury
Burns
Immunosuppression
Inflammation
Intensive care
Sepsis
Surgery
Trauma
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
08 Jul 2024
08 Jul 2024
Historique:
received:
09
04
2024
accepted:
21
06
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
8
7
2024
Statut:
epublish
Résumé
Acute kidney injury (AKI) is common in hospitalized patients and results in significant morbidity and mortality. The objective of the study was to explore the systemic immune response of intensive care unit patients presenting with AKI, especially the association between immune profiles and persistent AKI during the first week after admission following various types of injuries (sepsis, trauma, surgery, and burns). REALAKI is an ancillary analysis of the REAnimation Low Immune Status Marker (REALISM) cohort study, in which 359 critically ill patients were enrolled in three different intensive care units. Patients with end-stage renal disease were excluded from the REALAKI study. Clinical samples and data were collected three times after admission: at day 1 or 2 (D1-2), day 3 or 4 (D3-4) and day 5, 6 or 7 (D5-7). Immune profiles were compared between patients presenting with or without AKI. Patients with AKI at both D1-2 and D5-7 were defined as persistent AKI. A multivariable logistic regression model was performed to determine the independent association between AKI and patients' immunological parameters. Three hundred and fifty-nine patients were included in this analysis. Among them, 137 (38%) were trauma patients, 103 (29%) post-surgery patients, 95 (26%) sepsis patients, and 24 (7%) were burn patients. One hundred and thirty-nine (39%) patients presented with AKI at D1-2 and 61 (20%) at D5-7. Overall, 94% presented with persistent AKI at D5-7. Patients with AKI presented with increased pro and anti-inflammatory cytokines and altered innate and adaptive immune responses. The modifications observed in the immune profiles tended to be more pronounced with increasing KDIGO stages. In the logistic regression model, a statistically significant association was observed at D1-2 between AKI and CD10 Following various types of severe injuries, early AKI is associated with the initial inflammatory response. Presence of AKI at the end of the first week after injury is associated with injury-induced immunosuppression.
Sections du résumé
BACKGROUND
BACKGROUND
Acute kidney injury (AKI) is common in hospitalized patients and results in significant morbidity and mortality. The objective of the study was to explore the systemic immune response of intensive care unit patients presenting with AKI, especially the association between immune profiles and persistent AKI during the first week after admission following various types of injuries (sepsis, trauma, surgery, and burns).
METHODS
METHODS
REALAKI is an ancillary analysis of the REAnimation Low Immune Status Marker (REALISM) cohort study, in which 359 critically ill patients were enrolled in three different intensive care units. Patients with end-stage renal disease were excluded from the REALAKI study. Clinical samples and data were collected three times after admission: at day 1 or 2 (D1-2), day 3 or 4 (D3-4) and day 5, 6 or 7 (D5-7). Immune profiles were compared between patients presenting with or without AKI. Patients with AKI at both D1-2 and D5-7 were defined as persistent AKI. A multivariable logistic regression model was performed to determine the independent association between AKI and patients' immunological parameters.
RESULTS
RESULTS
Three hundred and fifty-nine patients were included in this analysis. Among them, 137 (38%) were trauma patients, 103 (29%) post-surgery patients, 95 (26%) sepsis patients, and 24 (7%) were burn patients. One hundred and thirty-nine (39%) patients presented with AKI at D1-2 and 61 (20%) at D5-7. Overall, 94% presented with persistent AKI at D5-7. Patients with AKI presented with increased pro and anti-inflammatory cytokines and altered innate and adaptive immune responses. The modifications observed in the immune profiles tended to be more pronounced with increasing KDIGO stages. In the logistic regression model, a statistically significant association was observed at D1-2 between AKI and CD10
CONCLUSION
CONCLUSIONS
Following various types of severe injuries, early AKI is associated with the initial inflammatory response. Presence of AKI at the end of the first week after injury is associated with injury-induced immunosuppression.
Identifiants
pubmed: 38978044
doi: 10.1186/s13054-024-04998-w
pii: 10.1186/s13054-024-04998-w
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
227Informations de copyright
© 2024. The Author(s).
Références
Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365–70.
doi: 10.1681/ASN.2004090740
pubmed: 16177006
Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411–23.
doi: 10.1007/s00134-015-3934-7
pubmed: 26162677
Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7:189–200.
doi: 10.1038/nrneph.2011.16
pubmed: 21364518
Zhang WR, Garg AX, Coca SG, Devereaux PJ, Eikelboom J, Kavsak P, et al. Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery. J Am Soc Nephrol. 2015;26:3123.
doi: 10.1681/ASN.2014080764
pubmed: 25855775
pmcid: 4657830
Payen D, Lukaszewicz A-C, Legrand M, Gayat E, Faivre V, Megarbane B, et al. A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. Burdmann EA, editor. PLoS ONE. 2012;7:e35838.
Murugan R, Wen X, Shah N, Lee M, Kong L, Pike F, et al. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol Dial Transpl. 2014;29:1854–64.
doi: 10.1093/ndt/gfu051
Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Critical Care Med. 2017;45:253–62.
Griffin BR, Teixeira JP, Ambruso S, Bronsert M, Pal JD, Cleveland JC, et al. Stage 1 acute kidney injury is independently associated with infection following cardiac surgery. J Thorac Cardiovasc Surg. 2021;161:1346–55.
doi: 10.1016/j.jtcvs.2019.11.004
pubmed: 32007252
Selby NM, Kolhe NV, McIntyre CW, Monaghan J, Lawson N, Elliott D, et al. Defining the cause of death in hospitalised patients with acute kidney injury. PLoS ONE. 2012;7:e48580.
doi: 10.1371/journal.pone.0048580
pubmed: 23133643
pmcid: 3487783
Rabb H, Griffin MD, McKay DB, Swaminathan S, Pickkers P, Rosner MH, et al. Inflammation in AKI: current understanding, key questions, and knowledge gaps. J Am Soc Nephrol. 2016;27:371–9.
doi: 10.1681/ASN.2015030261
pubmed: 26561643
Bihorac A, Baslanti TO, Cuenca AG, Hobson CE, Ang D, Efron PA, et al. Acute kidney injury is associated with early cytokine changes after trauma. J Trauma Acute Care Surg. 2013;74:1005–13.
doi: 10.1097/TA.0b013e31828586ec
pubmed: 23511138
pmcid: 3693855
Chawla LS, Seneff MG, Nelson DR, Williams M, Levy H, Kimmel PL, et al. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin J Am Soc Nephrol. 2007;2:22–30.
doi: 10.2215/CJN.02510706
pubmed: 17699383
Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL, et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193:281–7.
doi: 10.1164/rccm.201505-0995OC
pubmed: 26398704
pmcid: 4803059
Ls C, R B, A B, Sl G, Ed S, Sm B, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nature reviews Nephrology. 2017 [cited 2023 Dec 20];13. Available from: https://pubmed.ncbi.nlm.nih.gov/28239173/
Koyner JL, Mackey RH, Rosenthal NA, Carabuena LA, Kampf JP, Rodriguez T, et al. Clinical outcomes of persistent severe acute kidney injury among patients with kidney disease improving global outcomes stage 2 or 3 acute kidney injury. Am J Nephrol. 2022;53:816–25.
doi: 10.1159/000528158
pubmed: 36450235
Venet F, Textoris J, Blein S, Rol M-L, Bodinier M, Canard B, et al. Immune profiling demonstrates a common immune signature of delayed acquired immunodeficiency in patients with various etiologies of severe injury. Crit Care Med. 2022;50:565–75.
doi: 10.1097/CCM.0000000000005270
pubmed: 34534131
Rol M-L, Venet F, Rimmele T, Moucadel V, Cortez P, Quemeneur L, et al. The REAnimation low immune status markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients. BMJ Open. 2017;7:e015734.
doi: 10.1136/bmjopen-2016-015734
pubmed: 28637738
pmcid: 5726091
Disease K. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clin Pract Guideline Acute Kidney Injury. 2012;2:1.
Závada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, et al. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant. 2010;25:3911–8.
doi: 10.1093/ndt/gfp766
pubmed: 20100732
European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals :2011 2012. LU: Publications Office; 2013 [cited 2021 Feb 17]. https://doi.org/10.2900/86011
Rossaint J, Spelten O, Kässens N, Mueller H, Van Aken HK, Singbartl K, et al. Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling. Kidney Int. 2011;80:493–503.
doi: 10.1038/ki.2011.125
pubmed: 21562471
pmcid: 3156340
Singbartl K, Miller L, Ruiz-Velasco V, Kellum JA. Reversal of acute kidney injury-induced neutrophil dysfunction: a critical role for resistin. Crit Care Med. 2016;44:e492-501.
doi: 10.1097/CCM.0000000000001472
pubmed: 26646460
pmcid: 4896858
Singbartl K, Bishop JV, Wen X, Murugan R, Chandra S, Filippi M-D, et al. Differential effects of kidney-lung cross-talk during acute kidney injury and bacterial pneumonia. Kidney Int. 2011;80:633–44.
doi: 10.1038/ki.2011.201
pubmed: 21734638
pmcid: 3164921
Himmelfarb J, Le P, Klenzak J, Freedman S, McMenamin ME, Ikizler TA, et al. Impaired monocyte cytokine production in critically ill patients with acute renal failure. Kidney Int. 2004;66:2354–60.
doi: 10.1111/j.1523-1755.2004.66023.x
pubmed: 15569326
Lai T-S, Wang C-Y, Pan S-C, Huang T-M, Lin M-C, Lai C-F, et al. Risk of developing severe sepsis after acute kidney injury: a population-based cohort study. Crit Care. 2013;17:R231.
doi: 10.1186/cc13054
pubmed: 24119576
pmcid: 4056572
Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, et al. Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med. 2011;37:241–8.
doi: 10.1007/s00134-010-2089-9
pubmed: 21152901
Venet F, Tissot S, Debard A-L, Faudot C, Crampé C, Pachot A, et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock. Crit Care Med. 2007;35:1910–7.
doi: 10.1097/01.CCM.0000275271.77350.B6
pubmed: 17568330
Timmermans K, Kox M, Vaneker M, van den Berg M, John A, van Laarhoven A, et al. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med. 2016;42:551–61.
doi: 10.1007/s00134-015-4205-3
pubmed: 26912315
pmcid: 5413532
Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard A-L, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006;32:1175–83.
doi: 10.1007/s00134-006-0204-8
pubmed: 16741700
Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862–74.
doi: 10.1038/nri3552
pubmed: 24232462
pmcid: 4077177
Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, et al. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg. 2009;108:1841–7.
doi: 10.1213/ane.0b013e318195e11d
pubmed: 19448210
Andres-Hernando A, Okamura K, Bhargava R, Kiekhaefer CM, Soranno D, Kirkbride-Romeo LA, et al. Circulating IL-6 upregulates IL-10 production in splenic CD4+ T cells and limits acute kidney injury-induced lung inflammation. Kidney Int. 2017;91:1057–69.
doi: 10.1016/j.kint.2016.12.014
pubmed: 28214022
Singbartl K, Formeck CL, Kellum JA. Kidney-immune system crosstalk in AKI. Semin Nephrol. 2019;39:96–106.
doi: 10.1016/j.semnephrol.2018.10.007
pubmed: 30606411
Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015;26:2231–8.
doi: 10.1681/ASN.2014070724
pubmed: 25568178
pmcid: 4552117